Neurovascular bundle sparing in hypofractionated radiotherapy maintained with realistic treatment uncertainties.

Background And Purpose: Erectile dysfunction is a common side effect of radiotherapy for prostate cancer. To mitigate this toxicity, it has been suggested to limit the dose to critical nerves and vessels. We investigated the feasibility of sparing the neuro-vascular bundles (NVBs) in stereotactic body radiotherapy under the impact of realistic treatment uncertainties.

Materials And Methods: Non-sparing and sparing NVB treatment plans, delivered in 5 × 7.25 Gy, were automatically generated for 20 patients. Polynomial Chaos Expansion (PCE) was used to fast and accurately model the dose against treatment errors. PCE enabled a robustness evaluation of 100.000 treatment scenarios per plan, allowing to derive scenario distributions of clinically relevant dose volume histogram parameters and population dose histograms.

Results: An average decrease of 3.7 Gy and 4.4 Gy in the median of the NVB was achieved in the patient population in the presence of realistic treatment uncertainties for non-coplanar (NC) and coplanar (C) plans respectively. Sparing NVBs decreased planning target volume coverage by 2.1 % in on average, however clinical target volume (CTV) dose remained adequate. Population dose histograms showed that, while sparing does impact dose volume histogram parameters of organs at risk (OARs), the probability of a scenario exceeding planning constraints was limited.

Conclusion: NVB sparing was maintained in the presence of treatment uncertainties without compromising CTV coverage or OAR dose. There was no significant difference in the achieved NVB dose between NC and C plans. The clinical impact of the achieved sparing is subject of ongoing clinical trials.